Sven Sandin is associate professor of psychiatry and a member of the Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and a statistician in the medical epidemiology and biostatistics department at the Karolinska Institutet. He has more than 20 years of experience with epidemiological studies, primarily using the Swedish and Nordic population-based national registers to characterize the genetic basis of autism and familial recurrence of autism.

Sven Sandin
Associate professor of psychiatry
Icahn School of Medicine at Mount Sinai
From this contributor
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.

Autism is more heritable in boys than in girls
Explore more from The Transmitter
On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.

On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.
How developing neurons simplify their search for a synaptic mate
Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.

How developing neurons simplify their search for a synaptic mate
Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.
NIH autism database announcement raises concerns among researchers
The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.

NIH autism database announcement raises concerns among researchers
The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.